Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Kristensen

Showing results (241-250 of 320) with videos related to

Pageof 32
Sort By:
Acta Oncologica (Stockholm, Sweden)|March 27, 2020
Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction studyAnne Hansen Ree, Vigdis Nygaard, Kjetil Boye, et al.
Plos Computational Biology|May 15, 2013
Improving breast cancer survival analysis through competition-based multidimensional modelingErhan Bilal, Janusz Dutkowski, Justin Guinney, et al.
Cell Reports|December 26, 2019
miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast CancerDeepak Parashar, Anjali Geethadevi, Miriam Ragle Aure, et al.
Molecular Oncology|August 30, 2014
A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancerHans Kristian Moen Vollan, Oscar M Rueda, Suet-Feung Chin, et al.
Science Translational Medicine|April 19, 2013
Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancerAdam A Margolin, Erhan Bilal, Erich Huang, et al.
Cancer Cell|December 10, 2014
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancersPradeep Chaluvally-Raghavan, Fan Zhang, Sunila Pradeep, et al.
Future Oncology (London, England)|July 29, 2024
The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancerKamilla Fjermeros, Salim Ghannoum, Stephanie B Geisler, et al.
Breast Cancer Research : BCR|March 31, 2017
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcomeMiriam Ragle Aure, Valeria Vitelli, Sandra Jernström, et al.
Nature Communications|April 10, 2019
Breast cancer quantitative proteome and proteogenomic landscapeHenrik J Johansson, Fabio Socciarelli, Nathaniel M Vacanti, et al.
Trends in Ecology & Evolution|December 24, 2014
Genomics and the challenging translation into conservation practiceAaron B A Shafer, Jochen B W Wolf, Paulo C Alves, et al.
Pageof 32

Showing results (241-250 of 320) with videos related to

Sort By:
Pageof 32
Acta Oncologica (Stockholm, Sweden)|March 27, 2020
Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction studyAnne Hansen Ree, Vigdis Nygaard, Kjetil Boye, et al.
Plos Computational Biology|May 15, 2013
Improving breast cancer survival analysis through competition-based multidimensional modelingErhan Bilal, Janusz Dutkowski, Justin Guinney, et al.
Cell Reports|December 26, 2019
miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast CancerDeepak Parashar, Anjali Geethadevi, Miriam Ragle Aure, et al.
Molecular Oncology|August 30, 2014
A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancerHans Kristian Moen Vollan, Oscar M Rueda, Suet-Feung Chin, et al.
Science Translational Medicine|April 19, 2013
Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancerAdam A Margolin, Erhan Bilal, Erich Huang, et al.
Cancer Cell|December 10, 2014
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancersPradeep Chaluvally-Raghavan, Fan Zhang, Sunila Pradeep, et al.
Future Oncology (London, England)|July 29, 2024
The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancerKamilla Fjermeros, Salim Ghannoum, Stephanie B Geisler, et al.
Breast Cancer Research : BCR|March 31, 2017
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcomeMiriam Ragle Aure, Valeria Vitelli, Sandra Jernström, et al.
Nature Communications|April 10, 2019
Breast cancer quantitative proteome and proteogenomic landscapeHenrik J Johansson, Fabio Socciarelli, Nathaniel M Vacanti, et al.
Trends in Ecology & Evolution|December 24, 2014
Genomics and the challenging translation into conservation practiceAaron B A Shafer, Jochen B W Wolf, Paulo C Alves, et al.
Pageof 32